Eli Lilly says signs deal with Swixx Biopharma for Russia supplies - News Archive - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

Eli Lilly says signs deal with Swixx Biopharma for Russia supplies

MOSCOW, Mar 29 (PRIME) -- U.S. Eli Lilly confirms discontinuation of direct supplies to Russia, but signed an agreement with Switzerland's Swixx Biopharma for the supplies of Eli Lilly's pharmaceuticals to the country, a spokesperson for Russian division Lilly Pharma told PRIME on Wednesday.

"The company is carrying out and will continue to carry out supplies of life-saving drugs to the territory of the Russian Federation,Ф the spokesperson said.

УCompany Eli Lilly has signed an agreement with company Swixx Biopharma that includes the cession of the right to import products of the company, sell them on the territory of Russia and ensures the fulfillment of current liabilities concerning local production," the representative said.

Eli Lilly sells drugs for diabetes, cancer, osteoporosis, rheumatology, dermatology and psychiatry.


29.03.2023 13:21
Share |
To report an error select text and press Ctrl+Enter
Central Bank Official Rate
1W 1M 1Y
EUR 102.2453 -0.0032 26 sep
USD 96.1456 +0.1037 26 sep
Stock Market Indices
1D 1W 1M 1Y
micex 3049.07 0.00 23:52 25 sep
Stock Quotes in RUR
1D 1W 1M 1Y
gazp 165.65 -0.63 16:04 25 sep
lkoh 6450.00 -0.69 16:04 25 sep
rosn 513.90 0.00 22:20 25 sep
sber 251.11 -0.35 16:04 25 sep
MICEX Ruble Trading
1D 1W 1M 1Y
EURTD 102.1525 +0.1400 14:59 25 sep
USDTD 96.1475 +0.2375 16:04 25 sep